Related Experiment Video
Updated: Mar 21, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Personalized Glucose Management With AI: Pilot Study Using a Multiarmed Bandit Approach
Shinji Hotta1,2, Mikko Kytö3,4, Saila Koivusalo5
1Fujitsu Limited, 4-1-1 Kamikodanaka, Nakahara-ku, Kawasaki, Kanagawa, 211-8588, Japan, 81 44 777 1111.
Background:
Personalized behavioral recommendations through mobile apps have proven effective in preventing serious chronic diseases such as diabetes. Recent studies have primarily focused on optimizing personalized recommendations using reinforcement learning. However, the main problem with these approaches is that they focus on behavioral changes and overlook clinical outcomes.
Objective:
This study aimed to propose a method for online planning of dietary and exercise recommendations to optimize postprandial glucose levels through behavioral changes directly.
Methods:
The proposed method is a multiarmed bandit based on a two-stage reward prediction model, where an action is a combination of the total carbohydrate intake and postprandial walking duration, and the reward is the reduction in postprandial glucose levels. We implemented the prediction of the reward for each action based on the predicted behavioral responses to an action, and subsequently, the postprandial glycemic response.
Results:
In a simulation experiment, we demonstrated that the proposed online algorithm can significantly improve postprandial glucose levels with personalized recommendations, compared to the randomized policy. Furthermore, we conducted a small real-world experiment with a simplified proposed method involving a single update of the recommendation policy into a personalized one. For 6 participants, compared to the randomized policy, we observed a 23% improvement, on average, in actual glucose responses along with the behavioral adherence to the recommendations concerning carbohydrate intake and postprandial walking.
Conclusions:
The preliminary effectiveness of the proposed method was demonstrated from both the simulation experiment and the small real-world experiment. However, further longitudinal real-world experiments in patients with diabetes are needed to validate and generalize the findings.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Hypoglycemia and Glucagon
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
